Fundraising Fox

SONIRE Therapeutics

Palo Alto, US · Founded 2025 · Delaware corporation · 1 known investors

Healthtech

Founders & leadership

TS
Tohru SatohNamed on SEC filing

Board

DM
Dennis McWilliamsBoard director
KYKoji Yasuda
Koji YasudainBoard directorPrincipal at Fast Track Initiative
JO
Jun OkamotoBoard director
AA
Auriel AugustBoard director

Investors · 1

Fast Track InitiativeTokyo · $1.2M – $184M

Reported raises · per SEC filings

Form D private placements

$13.5M disclosed across 1 round · 2026

▶$13.5MraisedApr 2026 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Dennis McWilliamsDirector
  • Tohru SatohExecutive Officer, Director, Promoter
  • Koji YasudaDirector
  • Jun OkamotoDirector
  • Auriel AugustDirector
Offering amount
$13.5M
Amount sold
$13.5M
First sale
Mar 2026
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are SONIRE Therapeutics's investors?
SONIRE Therapeutics's investors include Fast Track Initiative.
How much funding has SONIRE Therapeutics raised?
SONIRE Therapeutics has disclosed $13.5M raised across 1 round.
Where is SONIRE Therapeutics headquartered?
SONIRE Therapeutics is headquartered in Palo Alto, US.